Pivot Bio CEO Net Worth

Last Updated Mar 10, 2025
CEO NameChris Abbott
NationalityUnited States
Net Worth Estimation$5 million

Chris Abbott's estimated net worth of around $5 million USD is primarily derived from his executive compensation, equity holdings, and performance-based incentives at Pivot Bio, as well as prior leadership roles at major agribusiness and investment firms. His financial status reflects both company growth and capitalization milestones achieved during his tenure.

Chris Abbott, CEO of Pivot Bio in the agriculture sector, has an estimated net worth of $5,000,000, which is 6.1% of the reported maximum ($70,000,000) and 5 times the minimum ($1,000,000). His net worth positions him in the lower range among agriculture CEOs based on these estimates.

Business Category: Agriculture

Minimum Net Worth (estimation): 1000000 USD
Maximum Net Worth (estimation): 70000000 USD


Chris Abbott Performance in Pivot Bio

Chris Abbott, CEO of Pivot Bio, demonstrates visionary leadership by pioneering microbial solutions that revolutionize sustainable agriculture. His data-driven decision-making accelerates product innovation and strategic partnerships, boosting company growth and market presence. Under Abbott's leadership, Pivot Bio has significantly enhanced its technological impact and scaled operations, positioning the firm as an industry leader in nitrogen-fixing biofertilizers.


Latest News

Pivot Bio Advances Sustainable Agriculture with CEO Chris Abbott Leading Innovation

Pivot Bio, led by CEO Chris Abbott, is a top agtech innovator delivering patented microbial nitrogen solutions to replace synthetic fertilizers, now used on over 15 million acres. The company aims to surpass $1 billion revenue by 2030 while expanding globally and launching digital tools for crop nutrition, earning multiple recognitions from Time and Fast Company. Abbott, formerly succeeding co-founder Karsten Temme as CEO, highlights innovation and sustainability at major agri-events worldwide.
Source: http://www.upstream.ag/p/pivot-bio-investor-day-highlights-and-analysis



Disclaimer.
The information provided in this document is for general informational purposes only and is not guaranteed to be complete. While we strive to ensure the accuracy of the content, we cannot guarantee that the details mentioned are up-to-date or applicable to all scenarios. Topics about Pivot Bio are subject to change from time to time.

Comments

No comment yet